Also trades as: IPOT.CN (CNQ) · $vol 0M
ISCNF OTC
Isracann Biosciences Inc.
1W: +900.0%
1M: +900.0%
3M: +0.0%
YTD: +900.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.00021
Volume68,183
Avg Volume56,030
Beta0.19
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAjay Singh Kaila
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-12-15
Websiteisracann.com
595 Burrard Street
Vancouver, BC V7X 1L3
CA
Vancouver, BC V7X 1L3
CA
604-394-2551
About Isracann Biosciences Inc.
Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure. Additionally, it ships its products internationally to Germany. The company rebranded to Isracann Biosciences Inc. in October 2019, having previously been known as Atlas Blockchain Group Inc. Founded in 2010, its corporate headquarters are situated in Vancouver, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found